Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia

  • STATUS
    Recruiting
  • days left to enroll
    67
  • participants needed
    66
  • sponsor
    Prince of Songkla University
Updated on 25 January 2021
fatigue
malnutrition
ferrous fumarate
haem

Summary

Iron deficiency anemia is a global health problem and the most common cause of anemia worldwide. Patients with iron deficiency and Iron deficiency anemia can present with a multitude of symptoms including fatigue, dyspnea on exertion, dysphagia, pallor, palpitations, headaches, tinnitus, taste disturbance and pica. Oral iron supplementation is associated with increasing hemoglobin in multiple studies in women, pregnant women and elderly patients. However, the optimal dose and frequency of oral iron supplementation for treatment remains unclear. The current proposed study attempts to address this gap in the literature.

Details
Condition Iron deficiency anemia, Iron Deficiency, anemia, iron deficiency
Treatment Ferrous fumarate
Clinical Study IdentifierNCT04130828
SponsorPrince of Songkla University
Last Modified on25 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Age 18-60 years
Outpatients with iron deficiency anemia defined as hemoglobin less than 12 g/dL in women or 13 g/dL in men; AND ferritin less than 30 ng/mL

Exclusion Criteria

Allergy to iron
Allergy to albendazole
Currently pregnancy
Currently breastfeeding
Known history of inflammatory bowel disease, celiac disease, inherited bleeding disorder, solid cancer, hematologic cancer or thalassemia
Renal impairment or glomerular filtration rate less than 30 ml/min/1.73m2
Hepatic impairment or Child Pugh score more than 7
Active bleeding define hemoglobin decrease more than 2 g/dL
Multivitamin and mineral supplement (35 mg or more of elemental iron per day) in 2 weeks prior to randomization
Non-literate
Subject withdrawal criteria
Intolerance to drugs
Active bleeding define hemoglobin decrease more than 2 g/dL
Major surgery
Blood transfusion
Loss follow-up more than 2 weeks
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note